Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...

EMPOWER-ED was a two-arm, individually randomized trial with a 6-month follow-up conducted at Veterans Health Administration ...

Although the correlate of protection is unknown, the findings show that standard doses should be used in infants.

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

Viking Therapeutics completes enrollment in a phase I maintenance study of VK2735, testing flexible oral and injectable ...

A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new ...

Once-daily oral ICP-332 results in large reduction in eczema scores and shows favorable safety in adults with moderate-to-severe atopic dermatitis.

Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

A large U.S. randomized trial published in the New England Journal of Medicine found that etomidate, compared with ketamine, ...